SCHEMBL19783899

SCHEMBL19783899

CC(C(=O)CC(=O)OCCl)N(CC1=CCCCC1)Cc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
HPGD P15428 2/20 0.40
MEN1 O00255 8/20 0.39
KMT2A Q03164 8/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HTT P42858 2/20 0.39
TSHR P16473 2/20 0.39
EPHX1 P07099 1/20 0.39
MAPT P10636 2/20 0.38
NPSR1 Q6W5P4 2/20 0.37
LMNA P02545 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
SLC22A2 O15244 1/20 0.37
SLC22A1 O15245 1/20 0.37
SLC22A3 O75751 1/20 0.37
ESR1 P03372 1/20 0.37
CHRM2 P08172 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
ADORA3 P0DMS8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22590994 0.91 TP53 (0.46) ALDH1A1HPGDMEN1KMT2AL3MBTL1
SCHEMBL19783897 0.87 MEN1 (0.47) ALDH1A1MEN1KMT2AL3MBTL1TSHR
SCHEMBL21220029 0.76 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AL3MBTL1MAPT
SCHEMBL1642202 0.76 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AL3MBTL1MAPT
SCHEMBL28295623 0.74 MEN1 (0.51) ALDH1A1HPGDMEN1KMT2AL3MBTL1
SCHEMBL20969294 0.70 MEN1 (0.56) HPGDMEN1KMT2A
SCHEMBL3651432 0.70 MEN1 (0.56) HPGDMEN1KMT2A
SCHEMBL5655931 0.67 KMT2A (0.56) ALDH1A1HPGDMEN1KMT2AL3MBTL1
SCHEMBL12492396 0.67 KMT2A (0.56) ALDH1A1HPGDMEN1KMT2AL3MBTL1
SCHEMBL5655937 0.67 KMT2A (0.56) ALDH1A1HPGDMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018011017-A1 7-SUBSTITUTED 1-PYRIDYL-NAPHTHYRIDINE-3-CARBOXYLIC ACID AMIDES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-01-18 WO disclosed